Etiometry

Company profile

About Etiometry

Etiometry is a leader in AI-driven clinical intelligence software designed specifically for high-acuity care teams in intensive care units. The company's comprehensive decision support platform delivers deep physiologic insights and supports the automation of hospital-defined clinical pathways, enabling clinicians to make timely decisions and actions that may improve outcomes, reduce costs, and ease the burden on care teams. The Etiometry platform is an end-to-end clinical data software solution for the collection, analysis, visualization, and archiving of ICU clinical data. It breaks down silos of information by aggregating lab results, vital signs, demographics, medications, fluid balance, peripheral devices, and waveforms on one screen. The platform's four main capabilities include Data Aggregation and Visualization for holistic patient views, Risk Analytics to get ahead of patient deterioration, Clinical Pathway Automation to drive consistent adherence to care protocols, and Quality Improvement tools to power continuous improvements and clinical research. With 11 FDA clearances, Etiometry is the only FDA-cleared clinical intelligence platform that empowers clinicians to proactively and personally drive care escalation and de-escalation decisions. The platform is utilized by leading academic medical centers recognized by U.S. News & World Report and top-ranked children's hospitals, including Boston Children's Hospital and Children's National Hospital. Etiometry's technology has been associated with significant clinical improvements, including up to 36% reduction in length of stay, up to 41% decrease in ICU readmissions, and up to 30% reduction in ventilation time. The platform has enabled over 150 studies and is particularly focused on precision intensive care, supporting individualized rather than population-based critical care approaches.

Company description · Etiometry official website